0001209191-22-031081.txt : 20220520 0001209191-22-031081.hdr.sgml : 20220520 20220520171446 ACCESSION NUMBER: 0001209191-22-031081 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220518 FILED AS OF DATE: 20220520 DATE AS OF CHANGE: 20220520 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CZEREPAK ELIZABETH CENTRAL INDEX KEY: 0001263500 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36150 FILM NUMBER: 22948776 MAIL ADDRESS: STREET 1: 201 ROUTE 17 NORTH CITY: RUTHERFORD STATE: NJ ZIP: 07070 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sorrento Therapeutics, Inc. CENTRAL INDEX KEY: 0000850261 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330344842 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4955 DIRECTORS PLACE CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-203-4100 MAIL ADDRESS: STREET 1: 4955 DIRECTORS PLACE CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: QUIKBYTE SOFTWARE INC DATE OF NAME CHANGE: 19920703 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-05-18 0 0000850261 Sorrento Therapeutics, Inc. SRNE 0001263500 CZEREPAK ELIZABETH C/O SORRENTO THERAPEUTICS, INC. 4955 DIRECTORS PLACE SAN DIEGO CA 92121 0 1 0 0 EVP & Chief Financial Officer Stock Option (right to buy) 1.51 2022-05-18 4 A 0 350000 0.00 A 2032-05-18 Common Stock 350000 350000 D 1/4th of the original number of shares subject to the option shall vest on May 18, 2023, and 1/48th of the original number of shares subject to the option shall vest on a monthly basis thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date. /s/ Henry Ji, Ph.D., as attorney-in-fact 2022-05-20